Surveillance of drug induced diseases in children

K P Kushwaha1, R B Verma, Y D Singh

  • 1Department of Pediatrics, B.R.D. Medical College, Gorakhpur.

Insights

Drug-induced diseases (DID) affected 1.004% of pediatric patients. Neonates were most affected, with Erythmatous maculopapular rashes being common, while aplastic anemia caused by Chloramphenicol was fatal.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Toxicology
  • Drug Safety in Children

Background:

  • Drug-induced diseases (DID) represent a significant concern in pediatric healthcare.
  • Understanding the incidence and patterns of DID is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the prevalence, clinical manifestations, and outcomes of drug-induced diseases in children under 14 years of age.
  • To identify common offending agents and risk factors associated with DID in a pediatric population.

Main Methods:

  • A two-year prospective hospital-based study involving 20,310 pediatric patients.
  • Diagnosis of DID based on clinical presentation and drug exposure history.
  • In-hospital intensive surveillance for children with severe reactions.

Main Results:

  • A total of 204 (1.004%) pediatric patients were diagnosed with DID.
  • DID was most prevalent in neonates (24.51%), with Erythmatous maculopapular rashes being the most common manifestation (67.12%).
  • Thrombophlebitis was common in infants and older children (41.56%).
  • Mortality rate was 4.41% (9 out of 204 cases).
  • Aplastic anemia, exclusively linked to Chloramphenicol, had a 100% mortality rate (7 cases).
  • Commonly implicated agents included baby powders, massage oils, ampicillin, co-trimoxazole, IV infusions, DPT, and measles vaccines.

Conclusions:

  • Drug-induced diseases are a notable cause of morbidity in children, particularly neonates.
  • Prompt identification and management of DID are essential to reduce mortality and improve pediatric patient care.
  • Surveillance for adverse drug reactions, including those from common substances and vaccines, is critical in pediatric settings.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...